2012•The Chinese Journal of Clinical PharmacologyRequires access

Bioequivalence of huperzine A sustain-release tablets in healthy volunteer

Chunjie Sha

Open publisher page 0 citations

Abstract

Objective To study the bioavailability of the tested and reference huperzine A sustain-release tablets in healthy male volunteers.Methods According to the four-crossing design,each volunteer was orally given huperzine A sustain-release tablets or huperzine A.The plasma concentrations were determined by LC-MS/MS.Pharmacokinetic parameters were obtained using DAS 2.0 program.Results The main pharmacokinetic parameters of huperzine A tablets test and reference were as follows: Cmax were(0.75±0.25),(1.57±0.44)ng·mL-1,Tmax were(5.77±3.60),(1.27±0.98)h,AUC0–t were(14.4±5.81),(15.1±5.66)ng·h·mL-1,AUC0-∞ were(17.1±7.29),(16.7±6.77)ng·h·mL-1,in 200 μg groups respectively.The relative bioavailability was(97.2± 24.4)%.The data of the reference and tested drugs were not different as shown by F test.Conclusion The result shows that the two huperzine A tablets made in two different preparations are bioequivalent.Huperzine A sustain-release tablets clearly have the characteristic of slow releasing properties.

About this research paper

What this paper is about

Objective To study the bioavailability of the tested and reference huperzine A sustain-release tablets in healthy male volunteers.Methods According to the four-crossing design,each volunteer was orally given huperzine A sustain-release tablets or huperzine A.The plasma concentrations were determined by LC-MS/MS.Pharmacokinetic parameters were obtained using DAS 2.0 program.Results The main pharmacokinetic parameters of huperzine A tablets test and reference were as follows: Cmax were(0.75±0.25),(1.57±0.44)ng·mL-1,Tmax were(5.77±3.60),(1.27±0.98)h,AUC0–t were(14.4±5.81),(15.1±5.66)ng·h·mL-1,AUC0-∞ were(17.1±7.29),(16.7±6.77)ng·h·mL-1,in 200 μg groups respectively.The relative bioavailability was(97.2± 24.4)%.The data of the reference and tested drugs were not different as shown by F test.Conclusion The result shows that the two huperzine A tablets made in two different preparations are bioequivalent.Huperzine A sustain-release tablets clearly have the characteristic of slow releasing properties.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the bioavailability of the tested and reference huperzine A sustain-release tablets in healthy male volunteers.Methods According to the four-crossing design,each volunteer was orally given huperzine A sustain-release tablets or huperzine A.The plasma concentrations were determined by LC-MS/MS.Pharmacokinetic parameters were obtained using DAS 2.0 program.Results The main pharmacokinetic parameters of huperzine A tablets test and reference were as follows: Cmax were(0.75±0.25),(1.57±0.44)ng·mL-1,Tmax were(5.77±3.60),(1.27±0.98)h,AUC0–t were(14.4±5.81),(15.1±5.66)ng·h·mL-1,AUC0-∞ were(17.1±7.29),(16.7±6.77)ng·h·mL-1,in 200 μg groups respectively.The relative bioavailability was(97.2± 24.4)%.The data of the reference and tested drugs were not different as shown by F test.Conclusion The result shows that the two huperzine A tablets made in two different preparations are bioequivalent.Huperzine A sustain-release tablets clearly have the characteristic of slow releasing properties.

Key concepts: Huperzine A, Bioequivalence, Volunteer, Bioavailability, Pharmacokinetics, Cmax, Pharmacology, Immediate release

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of huperzine A sustain-release tablets in healthy volunteer — Research Paper | ScholarLens